Download the full-sized PDF
Permanent link (DOI): https://doi.org/10.7939/R3T727F9J
This file is in the following communities:
|Pharmacy and Pharmaceutical Sciences, Faculty of|
This file is in the following collections:
|Journal Articles (Pharmacy)|
Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration Open Access
- Author or creator
- Additional contributors
Pluronic F-127 gels
- Type of item
- Journal Article (Published)
Abstract: Purpose: The aim of this work was to prepare poly n-butylcyanoacrylate (PNBCA) nanocapsules loaded with indomethacin and to evaluate the ability of this carrier system to deliver the drug systemically after its topical application. Methods: Poly n-butylcyanoacrylate (PNBCA) nanocapsules of indomethacin were prepared by interfacial polymerization. The physicochemical characterization of the PNBCA nanocapsules was performed by measuring the drug content by HPLC and analyzing the particle size using scanning electron microscopy. The in vitro permeation of indomethacin through excised rat skin and an artificial membrane was determined for PNBCA nanocapsules in pH 7.4 phosphate buffer (1), and in PLF-127 gel (II) and were compared against indomethacin incorporated into 25%w/w Pluronic F-127 (PLF-127) gel alone (III). The in vivo percutaneous absorption of indomethacin following the application of the PNBCA nanocapsules and a 25%w/w PLF-127 gel (111) was monitored by the determination of drug plasma levels in rats. RESULTS: The drug loading results indicated that similar to76.6% of indomethacin was loaded onto the PNBCA nanocapsules; the average particle size was 188 nm. The in vitro results indicated a rank order for the three formulations (1, II and 111) in both the flux at steady state and the cumulative amounts permeated at 8 hrs. The higher drug plasma levels over 6 hrs of indomethacin PNBCA nanocapsules are in agreement with the determined in vitro permeation results. Conclusion: The presented data show that indomethacin loaded PNBCA nanocapsules can improve the transdermal delivery of indomethacin compared to a conventional gel formulation using Pluronic F-127. This might be due to their ultra fine particle size and their hydrophilic and hydrophobic surface characteristics.
- Date created
- License information
- This work is made available under the terms of the Creative Commons Attribution - Share Alike 3.0 Unported license, http://creativecommons.org/licenses/by-sa/3.0/.
- Citation for previous publication
Shozo Miyazaki, Akie Takahashi, Wataru Kubo, John Bachynsky, Raimar Löbenberg. (2003). Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J Pharm Pharm Sci, 6(2), 238-245.
- Link to related item
- Date Uploaded
- Date Modified
- Audit Status
- Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 1024054
Last modified: 2015:10:12 11:24:56-06:00
Original checksum: 99f374366dae413ae77237fe8f7f7737
Well formed: true
File title: Nanocapsules
File author: Loebenberg
Page count: 8